TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pfizer AB
Closing information (x1000 DKK)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
1,399,240
|
2,850,910
|
487,030 |
| Financial expenses |
1,170
|
2,199
|
87 |
| Earnings before taxes |
76,397
|
29,961
|
20,926 |
| EBITDA |
75,384
|
153,126
|
24,465 |
| Total assets |
701,463
|
1,234,223
|
1,087,359 |
| Current assets |
682,556
|
1,218,408
|
945,987 |
| Current liabilities |
395,195
|
976,130
|
774,960 |
| Equity capital |
306,268
|
258,094
|
312,400 |
| - share capital |
23,288
|
24,303
|
25,943 |
| Employees (average) |
155
|
145
|
83 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
43.7%
|
20.9%
|
28.7% |
| Turnover per employee |
9,027
|
19,661
|
5,868 |
| Profit as a percentage of turnover |
5.5%
|
1.1%
|
4.3% |
| Return on assets (ROA) |
11.1%
|
2.6%
|
1.9% |
| Current ratio |
172.7%
|
124.8%
|
122.1% |
| Return on equity (ROE) |
24.9%
|
11.6%
|
6.7% |
| Change turnover |
-1,332,516
|
2,394,666
|
23,068 |
| Change turnover % |
-49%
|
525%
|
5% |
| Chg. No. of employees |
10
|
62
|
20 |
| Chg. No. of employees % |
7%
|
75%
|
32% |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.